Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: denosumab

FDA Issues Safety Alerts for Bisphosphonates & SGLT2 Inhibitors

Michele B. Kaufman, PharmD, BCGP  |  May 20, 2015

Safety The Food and Drug Administration (FDA) has updated the Warnings and Precautions sections of prescribing information for the bisphosphonate agents, including risedronate sodium tablets and combinations with calcium (Actonel/Atelvia), alendronate and combinations with vitamin D (Binosto/Fosamax), ibandronate (Boniva), etidronate (Didronel) and the RANK-ligand inhibitor denosumab (Prolia/Xgeva).1 This information relates to an increased risk for…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders

2014 ACR/ARHP Annual Meeting: Rheumatologic Research Uncovers Clues to Therapies

Susan Bernstein  |  April 1, 2015

Studies explore role of STING pathway in bone remodeling, denosumab to reduce fracture risk, autotaxin’s role in fibrosis, SSc

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:ACR/ARHP Annual MeetingBernsteinbone remodelingdenosumabfibrosisFracturesResearchrheumatologic diseaseSystemic sclerosistherapy

What’s New in Inflammatory Arthritis?

Thomas R. Collins  |  June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:AC&RadalimumabAmerican College of Rheumatology (ACR)BiosimilarsCollinsdruginfliximabMethotrexateradiographRheumatoid arthritistocilizumab

New Treatments Needed to Prevent Fractures in Osteoporosis

Ellen M. Field, MD, FACR, CCD  |  June 1, 2014

Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersRheumatoid Arthritis Tagged with:Biologicsbone remodelingimagingOsteoporosispatient careRheumatoid arthritisrheumatologistUltrasound

ACR/ARHP Annual Meeting 2012: New Insights into Bone Erosion and Formation Heighten Prospects for Therapies

Thomas R. Collins  |  April 1, 2013

Studies look at how the balance between osteoclast-mediated bone resorption and osteoblast mediated bone formation is undermined in people with arthritic conditions

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:ACR/ARHP Annual Meetingbone formationbone lossResearch

ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis

Thomas R. Collins  |  January 1, 2013

Rheumatology experts urge caution in using bisphosphonates to prevent bone loss

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:ACR/ARHP Annual Meetingbisphosphonatesbone lossOsteoporosisTreatment

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2013

Information on new approvals and medication safety rheumatologists need to know

Filed under:Drug Updates Tagged with:adalimumabDrugsFDAguidelineSafety

California Rheumatologists Explore Managed Care, Treatment Options

Larry Beresford  |  July 9, 2012

Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.

Filed under:Career DevelopmentConditionsEducation & TrainingLegislation & AdvocacyOsteoarthritis and Bone DisordersProfessional TopicsResearch Rheum Tagged with:ACAAffordable Care Act (ACA)BiologicsdrugHealthcare ReformLegislationLupusmanaged careMedicareOsteoporosispatient careradiographResearchRheumatoid arthritisrheumatologistSystemic lupus erythematosus

Space Traveling Mice Provide Insight into Osteoporosis

Richard Quinn  |  October 7, 2011

Researchers are using the unique, zero-gravity environment to develop therapies for the earthbound

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:bone densityOsteoporosisResearchspace travel

A Duet of Bone and the Immune System

Christian Beyer, MD, and Georg Schett, MD  |  July 12, 2011

Examining emerging perspectives in osteoimmunology

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Autoimmune diseaseboneDiagnostic CriteriaImmune SystemImmunologyPathogenesis

  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences